{"nct_id":"NCT00197041","title":"A Study to Evaluate the Safety, Immunogenicity and Efficacy of GlaxoSmithKline (GSK) Biologicals' Candidate Malaria Vaccine RTS,S/AS02A, When Administered to Children Aged 1 to 4 Years Living in a Malaria-endemic Region of Mozambique.","status":"COMPLETED","status_verified_date":"2016-09","start_date":"2003-07","start_date_type":null,"primary_completion_date":"2005-04","primary_completion_date_type":"ACTUAL","completion_date":"2005-04","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}